• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的筛查项目中漏诊和真阳性的乳腺癌。

Missed and true interval and screen-detected breast cancers in a population based screening program.

机构信息

Department of Radiology, Aalesund Hospital, Helse Sunnmøre HF, Aalesund, Norway.

出版信息

Acad Radiol. 2011 Apr;18(4):454-60. doi: 10.1016/j.acra.2010.11.014. Epub 2011 Jan 8.

DOI:10.1016/j.acra.2010.11.014
PMID:21216632
Abstract

RATIONALE AND OBJECTIVES

To increase radiologic knowledge, the distribution of mammographic features on prior screening mammograms of missed interval and screen-detected cancers was compared to the distribution on diagnostic mammograms of screen-detected cancers. The same variables were compared on mammograms of discordant and concordant screen-detected cancers.

MATERIALS AND METHODS

The study was performed in Møre og Romsdal County, Norway, as a part of the quality assurance of the Norwegian Breast Cancer Screening Program. Women were screened using analog techniques and diagnosed from 2002 to 2008. Prior and diagnostic mammograms of 81 interval and 123 screen-detected breast cancers in women aged 50 to 71 years were retrospectively reviewed and classified as either missed or true by four experienced breast radiologists. Mammographic features were classified according to a modified Breast Imaging Reporting and Data System.

RESULTS

Thirty percent (24 of 81) of the interval cancers and 21% (26 of 123) of the screen-detected cancers were classified as missed. Calcifications, alone or in association with mass or asymmetry, tended to be more common on prior mammograms of missed cancers compared to diagnostic mammograms of screen-detected cancers (34% [17 of 50] vs 21% [26 of 123], P = .114), whereas an opposite trend was seen for mass (54% [27 of 50] vs 68% [84 of 123], P = .109). Similar results were seen when comparing discordant and concordant cancers.

CONCLUSIONS

Calcifications represent a challenge in the interpretation of screening mammograms. For educational purposes, the importance of reviewing both interval and screen-detected cancers is obvious. Knowledge gained from systematic reviews might reduce the number of missed cancers on mammographic screening. Performing reviews according to established guidelines would make it possible to compare results across screening programs.

摘要

背景与目的

为了增加放射学知识,我们比较了漏诊和筛查检出乳腺癌的既往筛查钼靶片上的乳腺特征分布与筛查检出乳腺癌的诊断钼靶片上的分布。我们还比较了不一致和一致的筛查检出乳腺癌钼靶片上的相同变量。

材料与方法

该研究在挪威摩尔达伦郡进行,是挪威乳腺癌筛查计划质量保证的一部分。女性使用模拟技术进行筛查,并于 2002 年至 2008 年进行诊断。回顾性分析了 50 至 71 岁女性的 81 例漏诊和 123 例筛查检出乳腺癌的既往和诊断钼靶片,并由 4 位有经验的乳腺放射科医生进行分类,判断为漏诊或真实。根据改良的乳腺影像报告和数据系统对乳腺特征进行分类。

结果

30%(81 例中的 24 例)的间隔期癌症和 21%(123 例中的 26 例)的筛查检出癌症被归类为漏诊。与筛查检出乳腺癌的诊断钼靶片相比,漏诊乳腺癌的既往钼靶片中单纯或联合存在的钙化(34%[50 例中的 17 例]与 21%[123 例中的 26 例],P =.114)更常见,而肿块则相反(54%[50 例中的 27 例]与 68%[123 例中的 84 例],P =.109)。当比较不一致和一致的癌症时,也观察到了类似的结果。

结论

钙化是解释筛查钼靶片的一个挑战。为了教育目的,回顾漏诊和筛查检出乳腺癌的重要性是显而易见的。从系统综述中获得的知识可能会减少乳腺筛查中的漏诊癌症数量。按照既定指南进行审查将使跨筛查计划比较结果成为可能。

相似文献

1
Missed and true interval and screen-detected breast cancers in a population based screening program.基于人群的筛查项目中漏诊和真阳性的乳腺癌。
Acad Radiol. 2011 Apr;18(4):454-60. doi: 10.1016/j.acra.2010.11.014. Epub 2011 Jan 8.
2
Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.乳腺癌:全数字化乳腺摄影和屏片乳腺摄影的间期和筛查检出癌——回顾性研究结果。
Radiology. 2012 Aug;264(2):378-86. doi: 10.1148/radiol.12112074. Epub 2012 Jun 14.
3
Radiological review of prior screening mammograms of screen-detected breast cancer.筛查性乳腺钼靶 X 光检查检出乳腺癌的既往筛查钼靶 X 光片影像学评价
Eur Radiol. 2021 Apr;31(4):2568-2579. doi: 10.1007/s00330-020-07130-y. Epub 2020 Oct 1.
4
A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program.回顾新斯科舍省乳房筛查计划参与者中诊断出的间隔期乳腺癌。
Radiology. 2013 Jan;266(1):96-103. doi: 10.1148/radiol.12102348. Epub 2012 Nov 20.
5
Effect of computer-aided detection on independent double reading of paired screen-film and full-field digital screening mammograms.计算机辅助检测对配对的屏-片乳腺钼靶和全视野数字化乳腺钼靶独立双人阅片的影响。
AJR Am J Roentgenol. 2007 Feb;188(2):377-84. doi: 10.2214/AJR.05.2207.
6
Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.间隔期乳腺癌:在社区乳腺筛查计划中的绝对和相对发病率以及盲法审核。
Eur J Radiol. 2014 Feb;83(2):e84-91. doi: 10.1016/j.ejrad.2013.11.025. Epub 2013 Dec 6.
7
Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.复查设计对间期乳腺癌漏诊率的影响:基于人群的筛查项目中间期癌症的回顾性研究
Radiology. 2005 Nov;237(2):437-43. doi: 10.1148/radiol.2372041174.
8
[Breast carcinoma diagnosed in mammographic screening incidentally. Research on the radiologic signs in prior mammograms].[乳腺钼靶筛查中偶然诊断出的乳腺癌。对既往乳腺钼靶片中放射学征象的研究]
Radiol Med. 1999 Nov;98(5):342-6.
9
Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.基于荷兰性能指标的召回率对早期乳腺癌筛查检测的影响。
J Natl Cancer Inst. 2005 May 18;97(10):748-54. doi: 10.1093/jnci/dji131.
10
Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.激素疗法的使用与筛查时及两次乳房X线筛查之间检测到乳腺癌的风险
Int J Cancer. 2006 Jun 15;118(12):3112-7. doi: 10.1002/ijc.21742.

引用本文的文献

1
Exploring the Efficacy of Artificial Intelligence-Based Computer-Aided Detection for Breast Cancer Detection on Digital Mammograms.探索基于人工智能的计算机辅助检测在数字乳腺X线摄影中检测乳腺癌的效能。
J Korean Soc Radiol. 2025 May;86(3):391-406. doi: 10.3348/jksr.2024.0061. Epub 2025 May 28.
2
Enhancing detection of previously missed non-palpable breast carcinomas through artificial intelligence.通过人工智能提高对先前漏诊的不可触及性乳腺癌的检测。
Eur J Radiol Open. 2024 Dec 25;14:100629. doi: 10.1016/j.ejro.2024.100629. eCollection 2025 Jun.
3
Enhancing Radiologist Reading Performance by Ordering Screening Mammograms Based on Characteristics That Promote Visual Adaptation.
基于促进视觉适应的特征对筛查性乳房 X 光照片进行排序,以提高放射科医生的阅读表现。
Radiology. 2024 Oct;313(1):e240237. doi: 10.1148/radiol.240237.
4
Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.芬兰东部女性筛查检出乳腺癌和间隔期乳腺癌的放射学特征及其后续生存情况。
Sci Rep. 2024 May 1;14(1):10001. doi: 10.1038/s41598-024-60740-0.
5
How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway.乳腺 X 线筛查片上的人工智能标记与癌症位置如何对应?对 270 例挪威乳腺筛查乳腺癌病例的知情审查。
Eur Radiol. 2024 Sep;34(9):6158-6167. doi: 10.1007/s00330-024-10662-2. Epub 2024 Feb 23.
6
Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.在挪威乳房 X 光筛查 1996-2020 年间,患有浸润性筛检发现的癌症的女性的乳房 X 光特征与乳腺癌死亡风险。
Eur Radiol. 2024 May;34(5):3364-3374. doi: 10.1007/s00330-023-10369-w. Epub 2023 Nov 8.
7
Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.挪威乳腺 X 线筛查中的人工智能:包括 1254 例乳腺癌病例的癌症富集样本的回顾性分析。
Eur Radiol. 2023 May;33(5):3735-3743. doi: 10.1007/s00330-023-09461-y. Epub 2023 Mar 14.
8
Audit of Prior Screening Mammograms of Screen-Detected Cancers: Implications for the Delay in Breast Cancer Detection.筛查性乳腺癌钼靶检查的回顾性分析:对乳腺癌检出延误的影响。
Semin Ultrasound CT MR. 2023 Feb;44(1):62-69. doi: 10.1053/j.sult.2022.12.003. Epub 2022 Dec 27.
9
In-depth Retrospective Review of Originally Negative Screening Mammograms from Women with Confirmed Breast Cancer.对确诊乳腺癌女性最初筛查乳腺X线摄影阴性病例的深入回顾性研究
J Belg Soc Radiol. 2022 Nov 11;106(1):108. doi: 10.5334/jbsr.2796. eCollection 2022.
10
Body Mass Index Is Inversely Associated with Risk of Postmenopausal Interval Breast Cancer: Results from the Women's Health Initiative.体重指数与绝经后间隔期乳腺癌风险呈负相关:来自女性健康倡议的结果。
Cancers (Basel). 2022 Jun 30;14(13):3228. doi: 10.3390/cancers14133228.